Global burden of human papillomavirus and related diseases
D Forman, C de Martel, CJ Lacey, I Soerjomataram… - Vaccine, 2012 - Elsevier
The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …
Systematic review of the incidence and prevalence of genital warts
H Patel, M Wagner, P Singhal, S Kothari - BMC infectious diseases, 2013 - Springer
Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
Background Quadrivalent human papillomavirus (HPV) vaccine has high efficacy in clinical
trials but no reports describe its effects at a population level. From July, 2007, Australia was …
trials but no reports describe its effects at a population level. From July, 2007, Australia was …
Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection
A Asiaf, ST Ahmad, SO Mohammad… - European Journal of …, 2014 - journals.lww.com
Human papillomavirus (HPV) infection is a central and necessary, although not sufficient,
cause of cervical cancer. Besides HPV, the additional multiple risk factors related with the …
cause of cervical cancer. Besides HPV, the additional multiple risk factors related with the …
Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme
Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines
to school girls since mid-2007 and a catch-up programme in the community to women aged …
to school girls since mid-2007 and a catch-up programme in the community to women aged …
Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program
Background There has been a rapid decline in the number of young heterosexuals
diagnosed with genital warts at outpatient sexual health services since the national human …
diagnosed with genital warts at outpatient sexual health services since the national human …
The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK
SC Woodhall, M Jit, K Soldan, G Kinghorn… - Sexually transmitted …, 2011 - sti.bmj.com
Objectives To estimate the loss of quality of life and cost of treatment associated with genital
warts seen in sexual health clinics. Methods A cross-sectional questionnaire study and case …
warts seen in sexual health clinics. Methods A cross-sectional questionnaire study and case …
Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program …
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …
The Australian experience with the human papillomavirus vaccine
SM Garland - Clinical therapeutics, 2014 - Elsevier
Objective The goal of this study was to review the current human papillomavirus (HPV)
vaccine program and its outcomes to date in Australia. Methods This was a review of the …
vaccine program and its outcomes to date in Australia. Methods This was a review of the …
Adolescent and young adult HPV vaccination in Australia: achievements and challenges
Australia commenced an ongoing school based government funded human
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …